Medworxx
Inc. (“Medworxx”) (TSXV:MWX),
a leader in patient flow solutions, announced today the agreement with
Greater East Midlands Commissioning Support Unit (GEM) to license
Medworxx Patient Flow for their annual reviews delivered within their
region covering a 4.5 million population and 13,000 beds in acute or
community- based hospitals, or non- hospital environments. GEM will have
access to the Medworxx Appropriate Length of Stay Audit Program
capability in undertaking their reviews.
Established in 2010, GEM is the NHS Clinical Support Unit (CSU) that
supports and works on behalf of the 20 Clinical Commissioning Groups
(CCGs) in the East Midlands area. These CCGs serve a population of over
4.500,000 and fund the provider trusts with over 9,000 medical, surgical
and community beds and 4,000 mental health places. GEM will be using
Medworxx Clinical Criteria to conduct reviews, snapshot audits and
ongoing embedded reviews. Medworxx Patient Flow will provide GEM with
the tools for demand capacity and planning to help ensure that, during
the audit, all patients in the region are receiving the right care at
the right time in the right place.
“GEM’s Utilisation Review (UR) has an established track record and
unique level of experience in delivering a UR programme, and we’re
excited to be supporting their programme to deliver its clients with
further potential to enhance reporting,” said Dan Matlow, President and
CEO at Medworxx. “With audit reviews licensed to GEM, there is the
potential to sell full licenses for operational use in the future.”
GEM has signed on to a three year commitment with Medworxx, and will
conduct a minimum of 11 reviews per annum to cover the inpatient and
other NHS services in the East Midlands catchment area. GEM will be
joining Medworxx UK clients’, The Royal Liverpool and Broadgreen
University Hospitals and the South Tees NHS Foundation Trusts, using the
robust Medworxx criteria to identify underlying reasons why there are
conservable days, in real time.
Our success to date in the UK has been fuelled by path-finder
organisations that recognise the value to the patient and the
organisation of basing patient care transition decisions on rigorous
objective criteria, rather than personal opinion, to identify & remove
barriers preventing effective patient flow.
About
Medworxx
Medworxx delivers health information technology solutions to over 350
hospitals internationally; including Canada, United States and United
Kingdom. Medworxx helps hospitals meet patient flow challenges, and
requirements in compliance and education. Medworxx Clinical Criteria
—flagship of Medworxx Patient Flow that includes electronic bed
management and independent assessment components—currently serves over
33% of the acute- care beds in Canada, and approximately 2,000 beds in
UK’s NHS. Founded in 2004, Medworxx Inc. is based in Toronto, ON, and
publicly traded on the TSX Venture Exchange: MWX
Visit www.medworxx.com
About GEM
GEM is an NHS service created by commissioners across the East Midlands
to provide flexible, dedicated, specialist support. Since April 2010,
GEM has worked alongside commissioners and providers who deliver health
services to over 4.5 million people.
Their services include providing NHS organisations with online business
intelligence and benchmarking to improve performance, help in
strengthening contracts to reflect best practice in care delivery,
procurement support, using evidence based tools to assess and improve
frontline care, communicating healthcare trends and sharing knowledge
and skills.
Visit: http://www.gemcsu.nhs.uk/gem/
Disclaimer
The statements made in this press release may contain forward-looking
statements that may involve a number of risks and uncertainties. Actual
events or results could differ materially from the company’s
expectations and projections. The TSX Venture Exchange has not reviewed
this press release and neither approved nor disapproved the information
contained in this press release.
Copyright Business Wire 2013